Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation in T1D Kidney Allograft Recipients
NCT00468117Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2007
- Primary completion
- Jul 2015
- Modality
- Cell Therapies
- Countries
- 2
01
Overview
Phase 3, open-label trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2007; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00468117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468117.